Precision Medicine and AIID_2026.06.10
Synergy of LLMs and Miniaturized CRISPR Systems in Ultra-Personalized Medicine
Analysis of the integration of autonomous LLM agents (CRISPR-GPT) with miniature Al3Cas12f nucleases to bypass AAV vector capacity barriers and radically compress the R&D cycle to 6 months.
Open report